First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer SAPIRSTEIN JAMES
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Romano Sarah
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer SAPIRSTEIN JAMES
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Romano Sarah
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Syage Jack
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Director KHOSLA CHAITAN PHD
First Wave BioPharma | 3: Initial statement of beneficial ownership of securities-Officer Syage Jack
First Wave BioPharma | 3: Initial statement of beneficial ownership of securities-Director KHOSLA CHAITAN PHD
First Wave BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Romano Sarah
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer SAPIRSTEIN JAMES
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Coelho Mary Theresa
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Director BORKOWSKI EDWARD
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Director CASAMENTO CHARLES J
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Riddell Alastair
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer SAPIRSTEIN JAMES
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Romano Sarah
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Romano Sarah
First Wave BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer SAPIRSTEIN JAMES
First Wave BioPharma | D: Filing D
No Data